Screening para infección por Chlamydia Trachomatis en mujeres
En el artículo de febrero de 2017 de la revista New England Journal of Medicine (https://www.ncbi.nlm.nih.gov/pubmed/28225683) sale esta revisión sobre la infección de transmisión sexual por Clamidia. Se recomienda screening para detectarla en mujeres jóvenes menores de 25 años y adolescentes sexualmente activas.
Puntos clave sobre el screning:
- Chlamydia is the most common infection reported in the United States, with more than 1.5 million reported cases of chlamydial infection in 2015 and many additional unreported cases.
- The highest rates of chlamydial infection are among persons between 15 and 24 years of age.
- Chlamydia is an important cause of pelvic inflammatory disease, infertility, and ectopic pregnancy.
- Data from a randomized, controlled trial and observational data have shown a reduced incidence of pelvic inflammatory disease among young women who undergo screening for chlamydia.
- Modern diagnostic tests are highly sensitive for the detection of chlamydia; testing can be performed on vaginal swabs or urine samples collected by the patient, which eliminates the need for a pelvic examination.
• All sexually active women younger than 25 years of age as well as older women at risk for chlamydia should be offered chlamydia screening annually.